ACADIAN ASSET MANAGEMENT LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 132 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,033
-14.8%
4,660,740
+1.7%
0.02%
-12.5%
Q2 2023$5,908
+20.2%
4,581,512
+23.0%
0.02%
+9.1%
Q1 2023$4,914
-7.5%
3,723,563
+5.1%
0.02%
-15.4%
Q4 2022$5,311
-99.8%
3,541,501
+61.6%
0.03%
+85.7%
Q3 2022$2,584,000
+3.1%
2,191,861
-1.2%
0.01%
+7.7%
Q2 2022$2,507,000
+3.2%
2,218,273
+172.9%
0.01%
+30.0%
Q1 2022$2,429,000
+56.8%
812,793
+38.9%
0.01%
+66.7%
Q4 2021$1,549,000
+160.8%
585,370
+245.1%
0.01%
+200.0%
Q4 2020$594,000
-79.5%
169,635
-85.9%
0.00%
-83.3%
Q3 2020$2,896,000
+12.1%
1,206,331
-14.5%
0.01%
+9.1%
Q2 2020$2,583,000
+26.1%
1,411,054
+7.4%
0.01%
-8.3%
Q1 2020$2,049,000
+2.3%
1,313,532
+40.4%
0.01%
+33.3%
Q4 2019$2,003,000
+230.5%
935,631
+188.7%
0.01%
+200.0%
Q3 2019$606,000
-8.6%
324,070
+27.4%
0.00%0.0%
Q2 2019$663,000
+556.4%
254,282
+548.3%
0.00%
Q1 2019$101,000
-79.2%
39,224
-70.4%
0.00%
-100.0%
Q3 2016$486,000
+38.5%
132,479
-21.6%
0.00%0.0%
Q1 2016$351,000
+494.9%
168,947
+767.2%
0.00%
Q4 2015$59,000
+5800.0%
19,481
+4605.6%
0.00%
Q3 2015$1,000
-93.8%
414
-91.8%
0.00%
Q2 2015$16,000
+6.7%
5,057
+21.8%
0.00%
Q1 2015$15,0004,1530.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders